- Previous Close
11.02 - Open
11.02 - Bid 11.10 x --
- Ask 11.10 x --
- Day's Range
11.02 - 11.20 - 52 Week Range
9.44 - 11.52 - Volume
48,900 - Avg. Volume
66,417 - Market Cap (intraday)
2.457B - Beta (5Y Monthly) 0.37
- PE Ratio (TTM)
10.47 - EPS (TTM)
1.06 - Earnings Date Feb 24, 2025 - Feb 28, 2025
- Forward Dividend & Yield 0.40 (3.64%)
- Ex-Dividend Date Aug 22, 2024
- 1y Target Est
--
Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, ASEAN countries, other Asian countries, and internationally. The company operates through three segments: Healthcare, Investments, and Others. It manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands; and invests in quoted securities. The company also owns and leases various investment properties. In addition, it provides family and tourist oriented leisure activities primarily in the form of oceanariums. Further, the company is involved in the property development services; letting out of office spaces; and management support services. Haw Par Corporation Limited was incorporated in 1969 and is based in Singapore.
www.hawpar.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: H02.SI
View MorePerformance Overview: H02.SI
Trailing total returns as of 12/27/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: H02.SI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: H02.SI
View MoreValuation Measures
Market Cap
2.46B
Enterprise Value
-783.51M
Trailing P/E
10.48
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
10.27
Price/Book (mrq)
0.66
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
98.06%
Return on Assets (ttm)
1.15%
Return on Equity (ttm)
6.61%
Revenue (ttm)
239.06M
Net Income Avi to Common (ttm)
234.43M
Diluted EPS (ttm)
1.06
Balance Sheet and Cash Flow
Total Cash (mrq)
482.88M
Total Debt/Equity (mrq)
0.98%
Levered Free Cash Flow (ttm)
33.41M